Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Receivables - Other: 2016-2022

Historic Receivables - Other for Niagen Bioscience (NAGE) over the last 7 years, with Dec 2022 value amounting to $3.1 million.

  • Niagen Bioscience's Receivables - Other rose 52.17% to $3.5 million in Q1 2023 from the same period last year, while for Mar 2023 it was $3.5 million, marking a year-over-year increase of 52.17%. This contributed to the annual value of $3.1 million for FY2022, which is 47.62% up from last year.
  • Per Niagen Bioscience's latest filing, its Receivables - Other stood at $3.1 million for FY2022, which was up 47.62% from $2.1 million recorded in FY2021.
  • Niagen Bioscience's 5-year Receivables - Other high stood at $3.1 million for FY2022, and its period low was $700,000 during FY2018.
  • For the 3-year period, Niagen Bioscience's Receivables - Other averaged around $2.0 million, with its median value being $2.1 million (2021).
  • Per our database at Business Quant, Niagen Bioscience's Receivables - Other crashed by 30.00% in 2018 and then soared by 133.33% in 2021.
  • Niagen Bioscience's Receivables - Other (Yearly) stood at $700,000 in 2018, then grew by 14.29% to $800,000 in 2019, then climbed by 12.50% to $900,000 in 2020, then surged by 133.33% to $2.1 million in 2021, then skyrocketed by 47.62% to $3.1 million in 2022.